BSCFX vs. BIOPX

Last updated Jun 26, 2026

BSCFX (Baron Small Cap Fund) and BIOPX (Baron Opportunity Fund) are both mutual funds - BSCFX is a Small Cap Growth Equities fund managed by Baron Capital Group, Inc., while BIOPX is a Large Cap Growth Equities fund managed by Baron Capital Group, Inc.. Over the past 10 years, BSCFX returned 10.51%/yr vs 21.79%/yr for BIOPX. Their correlation of 0.85 suggests significant overlap in exposure. BSCFX charges 1.29%/yr vs 1.31%/yr for BIOPX.

Performance

BSCFX vs. BIOPX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Baron Small Cap Fund (BSCFX) and Baron Opportunity Fund (BIOPX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BSCFX achieves a -1.76% return, which is significantly lower than BIOPX's 9.58% return. Over the past 10 years, BSCFX has underperformed BIOPX with an annualized return of 10.51%, while BIOPX has yielded a comparatively higher 21.79% annualized return.

BSCFX

• 1D: 1.44%
• 1M: 1.51%
• YTD: -1.76%
• 6M: -3.73%
• 1Y: -0.62%
• 3Y*: 7.92%
• 5Y*: 0.22%
• 10Y*: 10.51%

BIOPX

• 1D: -0.20%
• 1M: 2.14%
• YTD: 9.58%
• 6M: 7.86%
• 1Y: 23.15%
• 3Y*: 26.80%
• 5Y*: 9.38%
• 10Y*: 21.79%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BSCFX vs. BIOPX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
BSCFX Baron Small Cap Fund	-1.76%	-0.92%	13.11%	26.90%	-31.19%	15.42%	40.38%	34.60%	-7.39%	27.34%
BIOPX Baron Opportunity Fund	9.58%	19.44%	39.87%	49.55%	-42.96%	11.90%	88.78%	40.34%	8.06%	40.58%

Correlation

The correlation between BSCFX and BIOPX is 0.59, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.59
Correlation (3Y) Calculated over the trailing 3-year period	0.69
Correlation (5Y) Calculated over the trailing 5-year period	0.79
Correlation (10Y) Calculated over the trailing 10-year period	0.81
Correlation (All Time) Calculated using the full available price history since Feb 29, 2000	0.85

Over the past year, the correlation between BSCFX and BIOPX has dropped to 0.59 - well below their long-term average of 0.85, suggesting their price drivers have been diverging.

Return for Risk

BSCFX vs. BIOPX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BSCFX

BSCFX Risk / Return Rank: 3
BSCFX Sharpe Ratio Rank: 3
BSCFX Sortino Ratio Rank: 3
BSCFX Omega Ratio Rank: 3
BSCFX Calmar Ratio Rank: 3
BSCFX Martin Ratio Rank: 3

BIOPX

BIOPX Risk / Return Rank: 25
BIOPX Sharpe Ratio Rank: 23
BIOPX Sortino Ratio Rank: 24
BIOPX Omega Ratio Rank: 25
BIOPX Calmar Ratio Rank: 28
BIOPX Martin Ratio Rank: 27

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BSCFX vs. BIOPX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Baron Small Cap Fund (BSCFX) and Baron Opportunity Fund (BIOPX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BSCFX	BIOPX	Difference
Sharpe ratio: Return per unit of total volatility	-0.10	1.14	-1.25
Sortino ratio: Return per unit of downside risk	-0.02	1.69	-1.71
Omega ratio: Gain probability vs. loss probability	1.00	1.22	-0.22
Calmar ratio: Return relative to maximum drawdown	-0.12	1.66	-1.79
Martin ratio: Return relative to average drawdown	-0.31	5.37	-5.68

BSCFX vs. BIOPX - Sharpe Ratio Comparison

The current BSCFX Sharpe Ratio is -0.10, which is lower than the BIOPX Sharpe Ratio of 1.14. The chart below compares the historical Sharpe Ratios of BSCFX and BIOPX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

BSCFX vs. BIOPX - Drawdown Comparison

The maximum BSCFX drawdown since its inception was -55.59%, smaller than the maximum BIOPX drawdown of -67.91%. Use the drawdown chart below to compare losses from any high point for BSCFX and BIOPX.

Drawdown Indicators

	BSCFX	BIOPX	Difference
Max Drawdown Largest peak-to-trough decline	-55.59%	-67.91%	+12.32%
Max Drawdown (1Y) Largest decline over 1 year	-15.00%	-14.16%	-0.84%
Max Drawdown (3Y) Largest decline over 3 years	-26.91%	-26.34%	-0.57%
Max Drawdown (5Y) Largest decline over 5 years	-37.94%	-51.45%	+13.51%
Max Drawdown (10Y) Largest decline over 10 years	-39.58%	-51.45%	+11.87%
Current Drawdown Current decline from peak	-10.85%	-7.55%	-3.30%
Average Drawdown Average peak-to-trough decline	-11.08%	-16.84%	+5.76%
Ulcer Index Depth and duration of drawdowns from previous peaks	5.93%	4.38%	+1.55%

Volatility

BSCFX vs. BIOPX - Volatility Comparison

The current volatility for Baron Small Cap Fund (BSCFX) is 5.17%, while Baron Opportunity Fund (BIOPX) has a volatility of 10.58%. This indicates that BSCFX experiences smaller price fluctuations and is considered to be less risky than BIOPX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BSCFX	BIOPX	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.17%	10.58%	-5.41%
Volatility (6M) Calculated over the trailing 6-month period	13.39%	15.23%	-1.84%
Volatility (1Y) Calculated over the trailing 1-year period	17.94%	20.66%	-2.72%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	22.39%	27.02%	-4.63%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	22.37%	24.99%	-2.62%

BSCFX vs. BIOPX - Expense Ratio Comparison

BSCFX has a 1.29% expense ratio, which is lower than BIOPX's 1.31% expense ratio.

Dividends

BSCFX vs. BIOPX - Dividend Comparison

BSCFX's dividend yield for the trailing twelve months is around 9.67%, more than BIOPX's 3.87% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BIOPX Baron Opportunity Fund	3.87%	4.24%	4.95%	0.00%	0.00%	8.71%	6.96%	7.33%	5.29%	15.58%	13.52%	10.92%
BSCFX Baron Small Cap Fund	9.67%	9.50%	13.96%	3.04%	5.90%	12.47%	11.17%	9.60%	10.91%	13.57%	22.41%	12.56%

Frequently Asked Questions

Can I hold both BSCFX and BIOPX in my portfolio?

BSCFX and BIOPX have a correlation of 0.59, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BSCFX or BIOPX?

BIOPX has higher volatility (10.58%) compared to BSCFX (5.17%). In terms of maximum drawdown, BSCFX dropped -55.59% vs BIOPX's -67.91%.

Which has better risk-adjusted returns?

BIOPX currently has the higher Sharpe Ratio (1.14 vs -0.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.